Antibody affinity maturation strategies: Balancing potency, selectivity, and developability
09 Feb 2027
Lead Identification & Optimization
-
AI/ML-guided design is reshaping the workflow faster than the decision framework; how does this impact your current workflows?
-
Sequential vs. parallel multi-parameter optimization; can it all be done in a single pass?
-
Affinity maturation potentially creates developability and immunogenicity liabilities; how does one balance antibody the TPP and risks?
-
Affinity maturation from display technologies vs. immunization; how different are the approaches from these two discovery modalities?
-
When affinity maturation efforts have failed; what are the next steps?


